MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

BACKGROUND: A substantial impediment to progress in trials of new therapies in neuromuscular disorders is the absence of responsive outcome measures that correlate with patient functional deficits and are sensitive to early disease processes. Irrespective of the primary molecular defect, neuromuscul...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrow, Jasper M, Sinclair, Christopher D J, Fischmann, Arne, Machado, Pedro M, Reilly, Mary M, Yousry, Tarek A, Thornton, John S, Hanna, Michael G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672173/
https://www.ncbi.nlm.nih.gov/pubmed/26549782
http://dx.doi.org/10.1016/S1474-4422(15)00242-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672173/
https://www.ncbi.nlm.nih.gov/pubmed/26549782
http://dx.doi.org/10.1016/S1474-4422(15)00242-2

Ejemplares similares